Firefly Neuroscience is trading 6.44% up at $0.99, primarily as a broader pre-market recovery lifted major U.S. indices, including the Nasdaq Composite, up 1.06%.
- No new company-specific announcement was identified for September 17, 2026.
- Latest company news remains the September 8 CFO termination and accounting leadership change, which does not clearly explain the gain.
- Confidence is medium; the market backdrop is supportive, but company-specific coverage is limited.